Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 397

1.

Development of a prediction model for inpatient gout flares in people with comorbid gout.

Jatuworapruk K, Grainger R, Dalbeth N, Taylor WJ.

Ann Rheum Dis. 2019 Dec 6. pii: annrheumdis-2019-216277. doi: 10.1136/annrheumdis-2019-216277. [Epub ahead of print]

PMID:
31811060
2.

How flare prevention outcomes are reported in gout studies: A systematic review and content analysis of randomized controlled trials.

Stewart S, Tallon A, Taylor WJ, Gaffo A, Dalbeth N.

Semin Arthritis Rheum. 2019 Nov 11. pii: S0049-0172(19)30682-1. doi: 10.1016/j.semarthrit.2019.11.002. [Epub ahead of print]

PMID:
31796212
3.

Radiographic damage scores predict grip strength in patients with tophaceous gout.

Stewart S, Aati O, Horne A, Doyle AJ, Dalbeth N.

Rheumatology (Oxford). 2019 Dec 3. pii: kez588. doi: 10.1093/rheumatology/kez588. [Epub ahead of print] No abstract available.

PMID:
31794003
4.

The costs associated with ankylosing spondylitis/axial spondyloarthritis in Aotearoa/New Zealand.

White D, Lao C, Williams M, Lawrenson R, Dalbeth N.

N Z Med J. 2019 Nov 8;132(1505):10-19.

PMID:
31778368
5.

Population-specific factors associated with fractional excretion of uric acid.

Narang RK, Vincent Z, Phipps-Green A, Stamp LK, Merriman TR, Dalbeth N.

Arthritis Res Ther. 2019 Nov 12;21(1):234. doi: 10.1186/s13075-019-2016-6.

6.

The costs associated with ankylosing spondylitis/axial spondyloarthritis in Aotearoa/New Zealand.

White D, Lao C, Williams M, Lawrenson R, Dalbeth N.

N Z Med J. 2019 Nov 8;132(1505):38-47.

PMID:
31697662
7.

Bidirectional relationship between gout and diabetes mellitus in individuals after acute pancreatitis: a nationwide cohort study.

Cho J, Dalbeth N, Petrov MS.

J Rheumatol. 2019 Oct 15. pii: jrheum.190487. doi: 10.3899/jrheum.190487. [Epub ahead of print]

PMID:
31615915
8.

The effect of different styles of medical illustration on information comprehension, the perception of educational material and illness beliefs.

Krasnoryadtseva A, Dalbeth N, Petrie KJ.

Patient Educ Couns. 2019 Sep 27. pii: S0738-3991(19)30433-1. doi: 10.1016/j.pec.2019.09.026. [Epub ahead of print]

PMID:
31601448
9.

Gout.

Perez-Ruiz F, Dalbeth N.

Rheum Dis Clin North Am. 2019 Nov;45(4):583-591. doi: 10.1016/j.rdc.2019.08.001. Review.

PMID:
31564298
10.

Gout.

Dalbeth N, Choi HK, Joosten LAB, Khanna PP, Matsuo H, Perez-Ruiz F, Stamp LK.

Nat Rev Dis Primers. 2019 Sep 26;5(1):69. doi: 10.1038/s41572-019-0115-y. Review.

PMID:
31558729
11.

The Māori and Pacific specific CREBRF variant and adult height.

Metcalfe LK, Krishnan M, Turner N, Yaghootkar H, Merry TL, Dewes O, Hindmarsh JH, De Zoysa J, Dalbeth N, Stamp LK, Merriman TR, Smith G, Shepherd P, Murphy R.

Int J Obes (Lond). 2019 Sep 22. doi: 10.1038/s41366-019-0437-6. [Epub ahead of print]

PMID:
31543511
12.

Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout.

Bursill D, Taylor WJ, Terkeltaub R, Abhishek A, So AK, Vargas-Santos AB, Gaffo AL, Rosenthal A, Tausche AK, Reginato A, Manger B, Sciré C, Pineda C, van Durme C, Lin CT, Yin C, Albert DA, Biernat-Kaluza E, Roddy E, Pascual E, Becce F, Perez-Ruiz F, Sivera F, Lioté F, Schett G, Nuki G, Filippou G, McCarthy G, da Rocha Castelar Pinheiro G, Ea HK, Tupinambá HA, Yamanaka H, Choi HK, Mackay J, ODell JR, Vázquez Mellado J, Singh JA, Fitzgerald JD, Jacobsson LTH, Joosten L, Harrold LR, Stamp L, Andrés M, Gutierrez M, Kuwabara M, Dehlin M, Janssen M, Doherty M, Hershfield MS, Pillinger M, Edwards NL, Schlesinger N, Kumar N, Slot O, Ottaviani S, Richette P, MacMullan PA, Chapman PT, Lipsky PE, Robinson P, Khanna PP, Gancheva RN, Grainger R, Johnson RJ, Te Kampe R, Keenan RT, Tedeschi SK, Kim S, Choi SJ, Fields TR, Bardin T, Uhlig T, Jansen T, Merriman T, Pascart T, Neogi T, Klück V, Louthrenoo W, Dalbeth N.

Ann Rheum Dis. 2019 Nov;78(11):1592-1600. doi: 10.1136/annrheumdis-2019-215933. Epub 2019 Sep 9.

PMID:
31501138
13.

Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration.

Stamp LK, Chapman PT, Barclay M, Horne A, Frampton C, Merriman TR, Wright DFB, Drake J, Dalbeth N.

Clin Transl Sci. 2019 Aug 23. doi: 10.1111/cts.12686. [Epub ahead of print]

PMID:
31444839
14.

Management of complex gout in clinical practice: Update on therapeutic approaches.

Narang RK, Dalbeth N.

Best Pract Res Clin Rheumatol. 2018 Dec;32(6):813-834. doi: 10.1016/j.berh.2019.03.010. Epub 2019 Apr 12. Review.

PMID:
31427057
15.

Association Between User Engagement of a Mobile Health App for Gout and Improvements in Self-Care Behaviors: Randomized Controlled Trial.

Serlachius A, Schache K, Kieser A, Arroll B, Petrie K, Dalbeth N.

JMIR Mhealth Uhealth. 2019 Aug 13;7(8):e15021. doi: 10.2196/15021.

16.

Reply.

Choi H, Neogi T, Stamp L, Dalbeth N, Terkeltaub R.

Arthritis Rheumatol. 2019 Nov;71(11):1967-1968. doi: 10.1002/art.41065. Epub 2019 Sep 20. No abstract available.

PMID:
31379125
17.

Radiologic evidence of symmetric and polyarticular monosodium urate crystal deposition in gout - A cluster pattern analysis of dual-energy CT.

Yokose C, Dalbeth N, Wei J, Nicolaou S, Simeone FJ, Baumgartner S, Fung M, Zhang Y, Choi HK.

Semin Arthritis Rheum. 2019 Jul 11. pii: S0049-0172(19)30120-9. doi: 10.1016/j.semarthrit.2019.07.002. [Epub ahead of print]

PMID:
31371194
18.

The footwear experiences of people with gout: a qualitative study.

Frecklington M, Williams A, Dalbeth N, McNair P, Gow P, Rome K.

J Foot Ankle Res. 2019 Jul 12;12:38. doi: 10.1186/s13047-019-0349-7. eCollection 2019.

19.

The challenges of gout flare reporting: mapping flares during a randomized controlled trial.

Teoh N, Gamble GD, Horne A, Taylor WJ, Palmano K, Dalbeth N.

BMC Rheumatol. 2019 Jul 9;3:27. doi: 10.1186/s41927-019-0075-6. eCollection 2019.

20.

Human Cartilage Homogenates Influence the Crystallization of Monosodium Urate and Inflammatory Response to Monosodium Urate Crystals: A Potential Link Between Osteoarthritis and Gout.

Chhana A, Pool B, Wei Y, Choi A, Gao R, Munro J, Cornish J, Dalbeth N.

Arthritis Rheumatol. 2019 Dec;71(12):2090-2099. doi: 10.1002/art.41038. Epub 2019 Nov 6.

PMID:
31297987
21.

The effects of message framing on patients' perceptions and willingness to change to a biosimilar in a hypothetical drug switch.

Gasteiger C, Jones ASK, Kleinstäuber M, Lobo M, Horne R, Dalbeth N, Petrie KJ.

Arthritis Care Res (Hoboken). 2019 Jun 24. doi: 10.1002/acr.24012. [Epub ahead of print]

PMID:
31233269
22.

Concurrent validity of provisional remission criteria for gout: a dual-energy CT study.

Dalbeth N, Frampton C, Fung M, Baumgartner S, Nicolaou S, Choi HK.

Arthritis Res Ther. 2019 Jun 21;21(1):150. doi: 10.1186/s13075-019-1941-8.

23.

Does seeing personal medical images change beliefs about illness and treatment in people with gout? A randomised controlled trial.

Krasnoryadtseva A, Dalbeth N, Petrie K.

Psychol Health. 2019 Jun 11:1-17. doi: 10.1080/08870446.2019.1626396. [Epub ahead of print]

PMID:
31184207
24.

Gout, flares, and allopurinol use: a population-based study.

Proudman C, Lester SE, Gonzalez-Chica DA, Gill TK, Dalbeth N, Hill CL.

Arthritis Res Ther. 2019 May 31;21(1):132. doi: 10.1186/s13075-019-1918-7.

25.

Mouse models for human hyperuricaemia: a critical review.

Lu J, Dalbeth N, Yin H, Li C, Merriman TR, Wei WH.

Nat Rev Rheumatol. 2019 Jul;15(7):413-426. doi: 10.1038/s41584-019-0222-x. Review.

PMID:
31118497
26.

Effects of Allopurinol Dose Escalation on Bone Erosion and Urate Volume in Gout: A Dual-Energy Computed Tomography Imaging Study Within a Randomized, Controlled Trial.

Dalbeth N, Billington K, Doyle A, Frampton C, Tan P, Aati O, Allan J, Drake J, Horne A, Stamp LK.

Arthritis Rheumatol. 2019 Oct;71(10):1739-1746. doi: 10.1002/art.40929. Epub 2019 Aug 12.

PMID:
31081595
27.

How Footwear Is Assessed in Patient Reported Measures for People with Arthritis: A Scoping Review.

Tehan PE, Carroll M, Dalbeth N, Rome K.

PM R. 2019 May 7. doi: 10.1002/pmrj.12182. [Epub ahead of print]

PMID:
31063639
28.

Effects of a footwear intervention on foot pain and disability in people with gout: a randomised controlled trial.

Frecklington M, Dalbeth N, McNair P, Morpeth T, Vandal AC, Gow P, Rome K.

Arthritis Res Ther. 2019 Apr 24;21(1):104. doi: 10.1186/s13075-019-1886-y.

29.

The anatomical pathology of gout: a systematic literature review.

Towiwat P, Chhana A, Dalbeth N.

BMC Musculoskelet Disord. 2019 Apr 1;20(1):140. doi: 10.1186/s12891-019-2519-y.

30.

"Come and live with my feet and you'll understand" - a qualitative study exploring the experiences of retail footwear in women with rheumatoid arthritis.

Tehan PE, Morpeth T, Williams AE, Dalbeth N, Rome K.

J Foot Ankle Res. 2019 Mar 14;12:15. doi: 10.1186/s13047-019-0328-z. eCollection 2019.

31.

Bovine bone particulates containing bone anabolic factors as a potential xenogenic bone graft substitute.

Musson DS, Gao R, Watson M, Lin JM, Park YE, Tuari D, Callon KE, Zhu M, Dalbeth N, Naot D, Munro JT, Cornish J.

J Orthop Surg Res. 2019 Feb 20;14(1):60. doi: 10.1186/s13018-019-1089-x.

32.

Liposome-Mediated Drug Delivery in Larval Zebrafish to Manipulate Macrophage Function.

Wu Z, Koh B, Lawrence LM, Kanamala M, Pool B, Svirskis D, Dalbeth N, Astin JW, Crosier KE, Crosier PS, Hall CJ.

Zebrafish. 2019 Apr;16(2):171-181. doi: 10.1089/zeb.2018.1681. Epub 2019 Feb 6.

PMID:
30724716
33.

Overlay repair with a synthetic collagen scaffold improves the quality of healing in a rat rotator cuff repair model.

Zhu M, Tay ML, Callon K, Tuari D, Zhao L, Dray M, Zhang J, Dalbeth N, Munro J, Young S, Coleman B, Patel D, Cornish J, Musson D.

J Shoulder Elbow Surg. 2019 May;28(5):949-958. doi: 10.1016/j.jse.2018.11.044. Epub 2019 Feb 2.

PMID:
30723031
34.

Prevalence and discrimination of OMERACT-defined elementary ultrasound lesions of gout in people with asymptomatic hyperuricaemia: A systematic review and meta-analysis.

Stewart S, Maxwell H, Dalbeth N.

Semin Arthritis Rheum. 2019 Aug;49(1):62-73. doi: 10.1016/j.semarthrit.2019.01.004. Epub 2019 Jan 11.

PMID:
30709689
35.

Experience of finding footwear and factors contributing to footwear choice in people with gout: a mixed methods study using a web-based survey.

Brenton-Rule A, Dalbeth N, Edwards NL, Rome K.

J Foot Ankle Res. 2019 Jan 8;12:3. doi: 10.1186/s13047-018-0313-y. eCollection 2019.

36.

Objectively Assessed Foot and Ankle Characteristics in Patients With Systemic Lupus Erythematosus: A Comparison With Age- and Sex-Matched Controls.

Stewart S, Dalbeth N, Aiyer A, Rome K.

Arthritis Care Res (Hoboken). 2019 Jan 10. doi: 10.1002/acr.23832. [Epub ahead of print]

PMID:
30629828
37.

Interactions between serum urate-associated genetic variants and sex on gout risk: analysis of the UK Biobank.

Narang RK, Topless R, Cadzow M, Gamble G, Stamp LK, Merriman TR, Dalbeth N.

Arthritis Res Ther. 2019 Jan 9;21(1):13. doi: 10.1186/s13075-018-1787-5.

38.

Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study.

Dalbeth N, Jones G, Terkeltaub R, Khanna D, Fung M, Baumgartner S, Perez-Ruiz F.

Arthritis Res Ther. 2019 Jan 7;21(1):8. doi: 10.1186/s13075-018-1788-4.

39.

No association between ATP-binding cassette transporter G2 rs2231142 (Q141K) and urate-lowering response to febuxostat.

Stamp LK, Topless R, Miner JN, Dalbeth N, Merriman T.

Rheumatology (Oxford). 2019 Mar 1;58(3):547-548. doi: 10.1093/rheumatology/key423. No abstract available.

PMID:
30597115
40.

Genetic advances in gout: potential applications in clinical practice.

Tai V, Merriman TR, Dalbeth N.

Curr Opin Rheumatol. 2019 Mar;31(2):144-151. doi: 10.1097/BOR.0000000000000571.

PMID:
30575597
41.

Prevention and treatment of gout.

Stamp LK, Dalbeth N.

Nat Rev Rheumatol. 2019 Feb;15(2):68-70. doi: 10.1038/s41584-018-0149-7. No abstract available.

PMID:
30546062
42.

The Intentional Non-Adherence Scale (INAS): Initial development and validation.

Weinman J, Graham S, Canfield M, Kleinstäuber M, Perera AI, Dalbeth N, Petrie KJ.

J Psychosom Res. 2018 Dec;115:110-116. doi: 10.1016/j.jpsychores.2018.10.010. Epub 2018 Oct 21.

PMID:
30470309
43.

Basic Calcium Phosphate Crystals Induce Osteoarthritis-Associated Changes in Phenotype Markers in Primary Human Chondrocytes by a Calcium/Calmodulin Kinase 2-Dependent Mechanism.

Rong J, Pool B, Zhu M, Munro J, Cornish J, McCarthy GM, Dalbeth N, Poulsen R.

Calcif Tissue Int. 2019 Mar;104(3):331-343. doi: 10.1007/s00223-018-0494-1. Epub 2018 Nov 19.

PMID:
30456555
44.

How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based dose.

Stamp LK, Chapman PT, Barclay ML, Horne A, Frampton C, Tan P, Drake J, Dalbeth N.

Arthritis Res Ther. 2018 Nov 16;20(1):255. doi: 10.1186/s13075-018-1755-0.

45.

Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!

Stamp LK, Wright DFB, Dalbeth N.

Br J Clin Pharmacol. 2019 Jun;85(6):1378-1379. doi: 10.1111/bcp.13798. Epub 2018 Nov 12. No abstract available.

PMID:
30421456
46.

Gout in Aotearoa New Zealand: the equity crisis continues in plain sight.

Dalbeth N, Dowell T, Gerard C, Gow P, Jackson G, Shuker C, Te Karu L.

N Z Med J. 2018 Nov 9;131(1485):8-12. No abstract available.

PMID:
30408813
47.

Altered expression of the core circadian clock component PERIOD2 contributes to osteoarthritis-like changes in chondrocyte activity.

Rong J, Zhu M, Munro J, Cornish J, McCarthy GM, Dalbeth N, Poulsen RC.

Chronobiol Int. 2019 Mar;36(3):319-331. doi: 10.1080/07420528.2018.1540493. Epub 2018 Nov 7.

PMID:
30403881
48.

Patient education and engagement in treat-to-target gout care.

Neogi T, Dalbeth N.

Lancet. 2018 Oct 20;392(10156):1379-1381. doi: 10.1016/S0140-6736(18)32415-2. No abstract available.

49.

Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts.

Major TJ, Topless RK, Dalbeth N, Merriman TR.

BMJ. 2018 Oct 10;363:k3951. doi: 10.1136/bmj.k3951.

50.

Greater insulin response to acute fructose ingestion among Māori and Pacific people compared to European people living in Aotearoa New Zealand.

Murphy R, Gamble GD, House M, Pool B, Horne A, Merriman TR, Dalbeth N.

Intern Med J. 2019 Feb;49(2):196-202. doi: 10.1111/imj.14135.

PMID:
30298971

Supplemental Content

Loading ...
Support Center